Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study

BACKGROUND: To determine the safety and efficacy of intravitreal sirolimus and adjunct aflibercept in subjects with persistent, exudative age-related macular degeneration despite previous intravitreal anti-vascular endothelial growth factor (VEGF) treatment. METHODS: This institutional review board...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowe, Lucas W., Minturn, Robert J., Burgett, Lauren A., Bracha, Peter, Maturi, Raj K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814330/
https://www.ncbi.nlm.nih.gov/pubmed/36604756
http://dx.doi.org/10.1186/s40942-022-00437-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814330/
https://www.ncbi.nlm.nih.gov/pubmed/36604756
http://dx.doi.org/10.1186/s40942-022-00437-6

Ejemplares similares